feed,title,long_url,short_url
Benzinga,AstraZeneca's Asthma Drug Gets FDA Approval For Rare Disease Of Blood Vessel Inflammation,https://benzinga.com/general/biotech/24/09/40923602/astrazenecas-asthma-drug-gets-fda-approval-for-rare-disease-of-blood-vessel-inflammation,https://da.gd/57R16
Benzinga,$100 Invested In Amazon.com 10 Years Ago Would Be Worth This Much Today,https://benzinga.com/insights/news/24/09/40923567/100-invested-in-amazon-com-10-years-ago-would-be-worth-this-much-today,https://da.gd/U8ddnR
Benzinga,$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today,https://benzinga.com/insights/news/24/09/40923564/100-invested-in-this-stock-5-years-ago-would-be-worth-200-today,https://da.gd/g5sKuj
Benzinga,Novartis' Multiple Sclerosis Drug Data Shows Most Patients Remain With No Disability Progression For Up To Six Years,https://benzinga.com/general/biotech/24/09/40923550/novartis-multiple-sclerosis-drug-data-shows-most-patients-remain-with-no-disability-progression-f,https://da.gd/HGFN
